HIGHLIGHTS
- who: Minna Mutka from the Department of Pathology, HUSLAB, Helsinki University Hospital and University of Helsinki, FINu2011, Helsinki, Finland have published the Article: Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar, in the Journal: (JOURNAL)
- what: The aim of this research was to compare quantities and subtypes of Tils in primary tumors and their corresponding recurrences.
- future: Research is needed to understand better the function of CD4+ cells and their role in cancer immune escape.
SUMMARY
The authors studied the Tils . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.